Inventor
NAM HOON KWON
Inventor
KR
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides25%
G01NInvestigating or analysing materials by determining their chemical or physical properties25%
A61KPreparations for medical, dental or toiletry purposes15%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
C12NMicroorganisms or enzymes10%
C12YEnzymes10%
PatentTitleYear
11,965,038Pharmaceutical composition comprising antibody binding specifically to lysyl-tRNA synthetase N-terminus as effective ingredient for preventing or treating immune cell migration-related disease202411,685,791Antibody binding specifically to N-terminal region of lysyl-tRNA synthetase exposed on cell membrane202311,561,222Method for diagnosis of bile duct cancer using methionyl-tRNA synthetase in bile duct cell202311,518,817Monoclonal antibody specifically binding to MRS202211,378,572Therapeutic agent for immune cell migration-caused disease and method for screening same2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to ZYMEDI CO LTD (3)· patent assignee history
2022–2023Patents assigned to ONCOTAG DIAGNOSTICS CO LTD (2)· patent assignee history
2022–2024Based in KR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ZYMEDI CO LTD | 3 | 2022–2024 |
| ONCOTAG DIAGNOSTICS CO LTD | 2 | 2022–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| KR | 5 | 2022–2024 |